Publication Details

MR-spectroscopy guided target delineation for high-grade gliomas.

Pirzkall A, McKnight TR, Graves EE, Carol MP, Sneed PK, Wara WW, Nelson SJ, Verhey LJ, Larson DA. Int J Radiat Oncol Biol Phys. 2001; 50 (4): 915-28

Functional/metabolic information provided by MR-spectroscopy (MRSI) suggests MRI may not be a reliable indicator of active and microscopic disease in malignant brain tumors. We assessed the impact MRSI might have on the target volumes used for radiation therapy treatment planning for high-grade gliomas.

PubMedID: 11429219